08:54 AM EDT, 09/11/2025 (MT Newswires) -- Guardant Health ( GH ) said Thursday it has signed an agreement with LabFlorida, expanding access among the residents of senior living communities to its Guardant Shield, a blood test used as a primary screening option for colorectal cancer.

Under the terms of agreement, LabFlorida will serve as the exclusive distributor to senior living communities throughout Florida, Guardant Health ( GH ) said.

Financial terms of the deal were not disclosed.

Shares of the company were up 1% in recent premarket activity Thursday.